Viratek Inc.: The Costa Mesa drug development...

Viratek Inc.: The Costa Mesa drug development company reported a third-quarter profit of $263,000, or 1 cent a share. That was 6% higher than earnings of $249,000, or 1 cent a share, for the same period last year. Revenue rose 25% to $2.5 million from $2 million. For the first nine months of the year, the company posted a loss of $1.1 million, or 6 cents a share, compared to a loss of $573,000, or 3 cents a share, for the same period last year. Nine-month revenue increased 50% to $6 million from $4 million.